Prof. Dr. Turgay Çelikel
OncologyVerified
- 47+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Cancer Surgery
Lumpectomy
A comprehensive guide to lumpectomy (breast-conserving surgery) in Turkey. Learn how surgeons locate and excise breast tumours, the importance of clear surgical margins, survival evidence compared to mastectomy, realistic cosmetic expectations, approximate costs across European and overseas healthcare systems, hospital trip timelines, potential surgical complications, and key questions for your surgical oncology team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Cancer Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Lumpectomy
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Lumpectomy in Turkey: breast conservation and how it works
A lumpectomy, clinically termed breast-conserving surgery or wide local excision, is an operation designed to remove a breast tumour along with a surrounding rim of healthy tissue while preserving the natural breast. Unlike a mastectomy, which removes the entire breast organ, a lumpectomy maintains the remaining breast tissue, skin envelope, and nipple-areola complex. Hospitals in Turkey perform lumpectomy procedures for early-stage breast cancer and complex benign lesions, utilising pre-operative radiological localisation, margin evaluation, and sentinel lymph node biopsies. For an overview of surgical and medical cancer care, see our guide to oncology treatments in Turkey.
Lumpectomy is almost always paired with adjuvant whole-breast radiation therapy to eradicate any remaining microscopic cancer cells in the surrounding breast tissue. It represents the standard surgical option for patients with localised disease who wish to avoid total breast removal. This guide covers how the surgery works, evidence supporting long-term survival, surgical margins, approximate costs in Turkey against the UK, US and Germany, recovery milestones, and safety guidelines.
How is a lumpectomy performed step by step?
A lumpectomy involves precision surgical oncology and follows methodical steps to ensure complete tumour clearance and cosmetic preservation. If a tumour cannot be felt by hand (non-palpable), the procedure begins before surgery in the radiology department. A specialist radiologist uses ultrasound or mammography guidance to place a thin localisation wire, magnetic marker, or radio-opaque seed directly into the lesion to guide the operating surgeon.
In the operating theatre, the patient is placed under general anaesthesia. The surgical oncologist plans an incision that follows natural skin tension lines or curves along the areolar border to minimise post-operative scarring. The surgeon dissects down to the lesion and excises the tumour with an envelope of healthy tissue. Small titanium clips are placed within the cavity walls to mark the precise tumour bed, guiding radiation oncologists during subsequent targeted radiotherapy.
For patients with invasive breast cancer, the surgeon simultaneously performs a sentinel lymph node biopsy through a separate small incision in the axilla (armpit). A tracer dye or radioisotope identifies the primary draining lymph nodes, which are excised for histological examination. Finally, the remaining breast tissue is mobilised to close the surgical cavity, and the skin is closed with dissolvable sutures. The operation typically lasts between 60 and 90 minutes.
Does lumpectomy provide the same survival as mastectomy?
A primary concern for anyone diagnosed with breast cancer is whether preserving the breast compromises survival. Extensive clinical research over four decades provides a definitive answer. Landmark clinical trials, including the National Surgical Adjuvant Breast and Bowel Project (NSABP B-06) and the European Milan Trial, demonstrated that for early-stage invasive breast cancer (stages I and II), lumpectomy combined with radiation therapy yields identical overall survival rates to total mastectomy.
While overall survival is equivalent, local recurrence in the treated breast can be slightly higher than after mastectomy. However, modern multimodal treatment—combining clear surgical margins, whole-breast radiation, and targeted systemic therapies (hormone therapy, chemotherapy, or immunotherapy)—has reduced annual recurrence rates to under 1% in suitable candidates. A specialist multidisciplinary oncology team evaluates your pathology and tumour biology to confirm whether breast conservation provides safe oncological control.
What are surgical margins and why do they matter?
In oncological surgery, surgical margins are fundamental to preventing cancer recurrence. When the tissue specimen is removed, the pathologist coats its outer surfaces with coloured surgical inks to measure the distance between cancer cells and the inked tissue edge. Margins are classified into three distinct categories:
- Negative (clear) margins: No cancer cells touch the inked edge. Guidelines from the Society of Surgical Oncology (SSO) and ASTRO define a clear margin for invasive carcinoma as "no ink on tumour". For DCIS, a minimum 2 mm margin is widely recommended.
- Close margins: Cancer cells approach within 1 to 2 mm of the inked border, which may warrant multidisciplinary review or further excision.
- Positive margins: Cancer cells extend directly to the inked surface, indicating that microscopic tumour cells remain inside the breast cavity.
If final histopathology reveals positive margins, the patient must undergo a secondary procedure known as a margin re-excision. In international registries, re-excision is required in approximately 15% to 20% of lumpectomies. If clear margins cannot be obtained, conversion to mastectomy is advised.
Lumpectomy cost in Turkey compared with the UK, US and Germany
The cost of surgical breast cancer treatment varies significantly across countries depending on hospital infrastructure, theatre time, pathology techniques, and specialist medical fees. The figures presented below represent broad, approximate price ranges for a lumpectomy procedure and should be used solely as general guidance.
| Country | Approximate cost range |
|---|---|
| Turkey | €2,500 – €6,500 |
| United Kingdom | €6,000 – €14,000 |
| United States | €10,000 – €28,000 |
| Germany | €5,500 – €12,500 |
Several variables determine the final lumpectomy price. The primary cost factors include whether a tumour requires radiologic guidewire or seed localisation, whether a sentinel lymph node biopsy is performed, and whether intraoperative frozen-section margin analysis is utilised. In Turkey, surgical packages typically cover pre-operative consultations, surgical and anaesthetic fees, hospital stay for one or two nights, routine specimen histopathology, post-operative dressings, and airport transfers. You can request an itemised estimate through our free quote form.
Lumpectomy, mastectomy or oncoplastic surgery?
Choosing the right surgical approach depends on tumour size, breast volume, tumour location, genetic testing results, and personal preference. The following comparison outlines the primary surgical techniques available for early-stage breast cancer management:
| Surgical approach | Best suited to | Typical limits |
|---|---|---|
| Standard lumpectomy | Small, solitary tumours with favourable tumour-to-breast ratio | Requires adjuvant radiotherapy; risk of positive margins requiring re-excision |
| Oncoplastic lumpectomy | Moderate tumours where standard excision risks contour indentations | Requires advanced reconstructive training; may require surgery on the opposite breast for symmetry |
| Total mastectomy | Multicentric disease, extensive calcifications, or genetic mutations | Involves complete breast tissue removal; longer surgical time and complex reconstruction options |
Oncoplastic surgery combines cancer clearance with plastic surgical techniques. When a tumour is in a cosmetically sensitive area or represents a significant portion of breast volume, the surgeon rearranges the surrounding glandular tissue (volume displacement) or transfers adjacent tissue flaps (volume replacement) to prevent an indentation. Patients seeking international cancer care can review available options on our oncology treatments in Turkey hub.
Who is a candidate for breast-conserving surgery?
A lumpectomy is not appropriate for every patient with breast cancer. Candidacy is determined by clinical staging, mammographic findings, and individual medical history. You are generally a good candidate for breast-conserving surgery if you have:
- A solitary tumour relative to overall breast size that permits complete removal with clear margins.
- Early-stage invasive breast carcinoma (Stage I or Stage II) or localised ductal carcinoma in situ (DCIS).
- The medical ability and willingness to undergo standard post-operative whole-breast radiation therapy.
- No history of previous therapeutic radiation to the same breast or chest wall.
Conversely, breast conservation is usually contraindicated in specific clinical situations. Women with multicentric disease (tumours in multiple distinct quadrants) are not suitable because complete removal leaves severe distortion. Other contraindications include widespread suspicious microcalcifications, pregnancy where radiation cannot be safely given, prior chest radiation, or known genetic mutations (such as BRCA1 or BRCA2) where bilateral mastectomy is frequently recommended to manage elevated lifetime recurrence risk.
Realistic expectations and before-and-after changes
Understanding physical and cosmetic outcomes before surgery helps patients maintain realistic expectations. Immediately after a lumpectomy, the breast will appear swollen, bruised, and potentially firmer than normal due to internal fluid accumulation. Over two to three months, as surgical swelling resolves, the permanent shape of the breast emerges.
Clinical before-and-after photographs show preservation of natural breast contour, though subtle differences in symmetry, fullness, and nipple position are common. In tumours removed without oncoplastic reconstruction, a small indentation may remain at the excision site. Furthermore, subsequent radiation therapy can cause mild skin thickening, hyperpigmentation, or subtle contraction of the treated breast over the first year. Before-and-after images reflect surgical healing, but they cannot show internal oncological success, which depends strictly on microscopic pathology margins.
Your trip to Turkey and lumpectomy recovery timeline
Undergoing breast cancer surgery abroad requires structured clinical planning. International patients travelling to Turkey for a lumpectomy should expect to stay between 6 and 9 nights. You can read how it works to understand how records are reviewed before travel. Days 1 and 2 involve multidisciplinary consultations, repeat imaging, blood panels, and anaesthetic clearance. Surgery occurs on day 2 or 3, followed by a one-night hospital stay. The remaining days are spent resting while awaiting the comprehensive pathology report and attending follow-up wound checks.
Recovery progresses through defined physical milestones:
- Days 1 to 3: Mild to moderate soreness in the breast and axilla, manageable with oral analgesics. Patients wear a supportive, non-underwired compression bra around the clock.
- Week 1: Surgical dressings are checked, axillary drains (if placed) are removed, and the multidisciplinary team reviews the final margin status. Walking is encouraged, but lifting objects over 2 kilograms is restricted.
- Weeks 2 to 4: Gentle range-of-motion arm exercises help prevent shoulder stiffness. Most patients return to light desk duties.
- Weeks 4 to 6: Incisions are completely healed and internal tissue has stabilized, clearing the way for adjuvant whole-breast radiotherapy or systemic medical therapy.
Risks and complications of lumpectomy surgery
As with any surgical oncology procedure, a lumpectomy entails potential medical and surgical risks. Regulatory and professional bodies, such as the National Health Service (NHS), the American Cancer Society, and the European Society of Breast Cancer Specialists (EUSOMA), categorise potential complications into acute post-operative events and long-term sequelae.
Common, self-limiting side effects include localised bruising, temporary swelling, tenderness, and altered sensation or numbness around the incision or armpit. Less common complications include post-operative haematoma (blood collection requiring drainage), wound infection requiring antibiotics, and seroma formation (serous fluid collecting in the cavity bed). The primary oncological risk is close or positive surgical margins, which necessitates secondary re-excision surgery. If lymph nodes are excised from the axilla, there is a small risk of developing lymphedema (arm swelling), though this risk is considerably lower with sentinel node biopsy than with full axillary node dissection.
How to choose a breast cancer hospital and red flags
Selecting an international hospital for oncological care demands rigorous scrutiny. The treating institution should possess full accreditation from the Turkish Ministry of Health or international bodies such as Joint Commission International (JCI). The hospital must operate an active Breast Multidisciplinary Team (MDT), where surgical oncologists, medical oncologists, radiation oncologists, radiologists, and pathologists collaborate on treatment plans. Learn more about how it works when coordinating clinical care abroad. Submit your existing pathology and imaging via our free quote page for an oncology review.
Be vigilant against clinical red flags. Avoid clinics that agree to perform surgery without prior biopsy reports and imaging, facilities that do not have on-site intensive care or licensed pathology laboratories, coordinators who offer fixed pricing without reviewing clinical records, or any provider claiming that radiation therapy is never required following breast conservation.
Before confirming your procedure, discuss these essential questions with the clinical team:
- Is my tumour size and position fully compatible with breast-conserving surgery, or would neoadjuvant systemic therapy improve the surgical outcome?
- What localisation technique will be used if the tumour is non-palpable?
- Will a sentinel lymph node biopsy be conducted concurrently?
- What protocol is followed if the final pathology report shows positive margins?
- Will my complete pathology slides, histology reports, and operative records be provided in English for my medical team at home?
Hospitals with Oncology in Turkey
Frequently asked questions
A lumpectomy is a breast-conserving surgical procedure that removes a breast tumour or abnormal lesion along with a rim of healthy tissue, preserving the rest of the breast. It is commonly performed for early-stage breast cancer and is typically followed by radiation therapy to reduce the risk of cancer returning.
Yes. Major long-term clinical trials have demonstrated that for early-stage breast cancer, lumpectomy combined with whole-breast radiation therapy offers the same overall survival rate as a total mastectomy. While local recurrence in the breast can be slightly higher, modern radiation and systemic therapies make recurrence rates very low in suitable patients.
A lumpectomy in Turkey generally costs between €2,500 and €6,500, compared with €6,000 to €14,000 in the UK and upwards of €10,000 in the US. The exact price depends on tumour localisation methods, sentinel node biopsy, pathology analysis, and whether oncoplastic reconstruction is performed. Clinics confirm final pricing in a written quote.
Before-and-after results show preservation of the natural breast shape, with small surgical scars that fade over several months. Mild asymmetry or a slight indentation can occur depending on tumour size and location. Adjuvant radiotherapy may cause slight skin firmness or colour changes over time. Pre-operative photographs help guide realistic cosmetic expectations.
Most patients manage post-operative soreness within three to five days and return to light desk activities within one to two weeks. Complete surgical incision healing takes four to six weeks, at which stage patients are usually ready to begin adjuvant treatments, such as radiation therapy, under the guidance of their oncology team.
The operation is performed under general anaesthesia, so you feel nothing during the procedure. Afterwards, most patients experience mild to moderate discomfort, tightness, or bruising in the breast and armpit. This pain is typically well controlled with standard prescribed oral painkillers and begins easing significantly after the first few days.
A lumpectomy permanently removes the identified tumour. When combined with clear surgical margins, post-operative radiation, and any recommended systemic therapies, long-term local cancer control is excellent. Regular ongoing mammograms and clinical check-ups remain essential to monitor both breasts over your lifetime.
Lumpectomy is a well-established, standard oncological operation with low serious complication rates when performed in an accredited hospital. Potential risks include localised bleeding, infection, fluid collections (seroma), and altered breast sensation. The primary oncological risk is positive surgical margins, which may require a secondary re-excision to ensure complete cancer clearance.
Lumpectomy is often preferred because it preserves natural breast tissue and involves a shorter recovery than total mastectomy. However, neither option is universally suitable. Mastectomy is necessary for multicentric tumours, widespread calcifications, prior chest radiation, or high-risk genetic mutations. Your multidisciplinary oncology team will determine which procedure is oncologically appropriate for you.
Patients travelling to Turkey for a lumpectomy typically stay between six and nine nights. This timeframe allows for pre-operative consultations, imaging, surgical localisation, the operation itself, a one-night hospital stay, and essential post-operative monitoring while awaiting final pathology margin results before receiving clearance to fly home.
Patient stories